Exploring frontiers: Use of complementary and alternative medicine among patients with early-stage breast cancer

Breast

Volumn 23, Issue 3, 2014, Pages 279-285

  Saghatchian, Mahasti ^a   Bihan, Céline ^a   Chenailler, Catherine ^a   Mazouni, Chafika ^a   Dauchy, Sarah ^a   Delaloge, Suzette ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Anti oxidants; Breast cancer; Complementary and alternative medicine; Herbs; Phytoestrogens; Vitamins

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ALTERNATIVE MEDICINE; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER STAGING; EDUCATIONAL STATUS; FEMALE; HEALTH STATUS; HOMEOPATHY; HUMAN; MAJOR CLINICAL STUDY; PATIENT ATTITUDE; PATIENT SATISFACTION; PHYTOTHERAPY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; TREATMENT RESPONSE; VERY ELDERLY; ADJUVANT CHEMOTHERAPY; ADVERSE EFFECTS; AGE; BREAST NEOPLASMS; CROSS-SECTIONAL STUDY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FRANCE; HEALTH LITERACY; MIDDLE AGED; MOTIVATION; NEEDS ASSESSMENT; PATHOLOGY; PROCEDURES; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

AGE FACTORS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; EDUCATIONAL STATUS; FEMALE; FRANCE; HEALTH LITERACY; HUMANS; MIDDLE AGED; MOTIVATION; NEEDS ASSESSMENT; NEOPLASM STAGING; PROSPECTIVE STUDIES;

EID: 84899922737     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2014.01.009     Document Type: Article

References (23)

1. Harris P.E., Cooper K.L., Relton C., Thomas K.J. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J Clin Pract 2012 Oct, 66(10):924-939.
2. Barnes P.M., Bloom B., Nahin R.L. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Rep 2008 Dec, 10(12):1-23.
3. Frenkel M., Cohen L., Peterson N., Palmer J.L., Swint K., Bruera E. Integrative medicine consultation service in a comprehensive cancer center: findings and outcomes. Integr Cancer Ther 2010 Sep, 9(3):276-283.
4. Trager-Maury S., Tournigand T., Maindrault-Goebel F., Afchain P., De Gramont A., Garcia-Larnicol M., et al. Use of complementary medicine by cancer patients in a French oncology department. Bull Cancer 2007, 94(11):1017-1025.
5. Risberg T., Kolstad A., Bremnes Y., Holte H., Wist E.A., Mella O., et al. Knowledge of and attitudes toward complementary and alternative therapies; a national multicenter study of oncology professionals in Norway. Eur J Cancer 2004, 40(4):529-535.
6. Munstedt K., Entezami A., Wartenberg A., Kullmer U. The attitudes of physicians and oncologists towards unconventional cancer therapies (UCT). Eur J Cancer 2000, 36(16):2090-2095.
7. Gerber B., Scholz C., Reimer T., Briese V., Janni W. Complementary and alternative therapeutic approaches in patients with early breast cancer: a systematic review. Breast Cancer Res Treat 2006, 95(3):199-209.
8. Lang M., Henson R., Braconi C., Patel T. Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells. Liver Int 2009 May, 29(5):670-677.
9. Ramanathan B., Jan K.Y., Chen C.H., Hour T.C., Yu H.J., Pu Y.S. Resistance to paclitaxel is proportional to cellular total antioxidant capacity. Cancer Res 2005 Sep 15, 65(18):8455-8460.
10. Rockwell S., Liu Y., Higgins S.A. Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh. Breast Cancer Res Treat 2005, 90(3):233-239.
11. Unger M., Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom 2004, 18(19):2273-2281.
12. Vadgama J.V., Wu Y., Shen D., Hsia S., Block J. Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells. Anticancer Res 2000, 20(3A):1391-1414.
13. Pathak A.K., Bhutani M., Guleria R., Bal S., Mohan A., Mohanti B.K., et al. Chemotherapy alone vs. chemotherapy plus high dose multiple antioxidants in patients with advanced non-small cell lung cancer. JAm Coll Nutr 2005, 24(1):16-21.
14. Portenoy R.K. Treatment of cancer pain. Lancet 2011 Jun 25, 377(9784):2236-2247.
15. Liao G.S., Apaya M.K., Shyur L.F. Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy. Evid Based Complement Altern Med 2013, 2013:437948.
16. Eisenberg D.M., Kessler R.C., Van Rompay M.I., Kaptchuk T.J., Wilkey S.A., Appel S., et al. Perceptions about complementary therapies relative to conventional therapies among adults who use both: results from a national survey. Ann Intern Med 2001, 135(5):344-351.
17. Dy G.K., Bekele L., Hanson L.J., Furth A., Mandrekar S., Sloan J.A., et al. Complementary and alternative medicine use by patients enrolled onto phase I clinical trials. JClin Oncol 2004, 22(23):4810-4815.
18. Molassiotis A., Fernadez-Ortega P., Pud D., Ozden G., Scott J.A., Panteli V., et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol 2005, 16(4):655-663.
19. Pedersen C.G., Christensen S., Jensen A.B., Zachariae R. Prevalence, socio-demographic and clinical predictors of post-diagnostic utilisation of different types of complementary and alternative medicine (CAM) in a nationwide cohort of Danish women treated for primary breast cancer. Eur J Cancer 2009, 45(18):3172-3181.
20. Helyer L.K., Chin S., Chui B.K., Fitzgerald B., Verma S., Rakovitch E., et al. The use of complementary and alternative medicines among patients with locally advanced breast cancer - a descriptive study. BMC Cancer 2006, 6:39.
21. Moran M.S., Ma S., Jagsi R., Yang T.I., Higgins S.A., Weidhaas J.B., et al. Aprospective, multicenter study of complementary/alternative medicine (CAM) utilization during definitive radiation for breast cancer. Int J Radiat Oncol Biol Phys 2013, 85:40-46.
22. Xu L., Li H., Xu Z., Wang Z., Liu L., Tian J., et al. Multi-center randomized double-blind controlled clinical study of chemotherapy combined with or without traditional Chinese medicine on quality of life of postoperative non-small cell lung cancer patients. BMC Complement Altern Med 2012, 12(1):112.
23. Leach M.J. Profile of the complementary and alternative medicine workforce across Australia, New Zealand, Canada, United States and United Kingdom. Complement Ther Med 2013 Aug, 21(4):364-378.